Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Functional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers.

Benkelfat C, Bradwejn J, Meyer E, Ellenbogen M, Milot S, Gjedde A, Evans A.

Am J Psychiatry. 1995 Aug;152(8):1180-4.

PMID:
7625467
2.

CCK4-induced panic in healthy subjects I: psychological and cardiovascular effects.

Jerabek I, Boulenger JP, Bradwejn J, Lavallée YJ, Jolicoeur FB.

Eur Neuropsychopharmacol. 1999 Jan;9(1-2):149-55.

PMID:
10082241
3.

Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans: a comparison of two time points.

Javanmard M, Shlik J, Kennedy SH, Vaccarino FJ, Houle S, Bradwejn J.

Biol Psychiatry. 1999 Apr 1;45(7):872-82.

PMID:
10202575
4.

Functional neuroanatomy of CCK-4-induced panic attacks in healthy volunteers.

Eser D, Leicht G, Lutz J, Wenninger S, Kirsch V, Schüle C, Karch S, Baghai T, Pogarell O, Born C, Rupprecht R, Mulert C.

Hum Brain Mapp. 2009 Feb;30(2):511-22.

PMID:
18095276
5.

CCK4-induced panic in healthy subjects II: neurochemical correlates.

Jerabek I, Boulenger JP, Bradwejn J, Drumheller A, Lavallée YJ, Jolicoeur FB.

Eur Neuropsychopharmacol. 1999 Jan;9(1-2):157-64.

PMID:
10082242
6.

Site of opioid action in the human brain: mu and kappa agonists' subjective and cerebral blood flow effects.

Schlaepfer TE, Strain EC, Greenberg BD, Preston KL, Lancaster E, Bigelow GE, Barta PE, Pearlson GD.

Am J Psychiatry. 1998 Apr;155(4):470-3.

PMID:
9545990
7.

Neuroanatomical correlates of a lactate-induced anxiety attack.

Reiman EM, Raichle ME, Robins E, Mintun MA, Fusselman MJ, Fox PT, Price JL, Hackman KA.

Arch Gen Psychiatry. 1989 Jun;46(6):493-500.

PMID:
2786401
8.

The panic-inducing properties of the cholecystokinin tetrapeptide CCK4 in patients with panic disorder.

van Megen HJ, Westenberg HG, Den Boer JA, Kahn RS.

Eur Neuropsychopharmacol. 1996 Aug;6(3):187-94.

PMID:
8880078
9.

Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks.

van Megen HJ, Westenberg HG, den Boer JA, Slaap B, Scheepmakers A.

Psychopharmacology (Berl). 1997 Feb;129(4):357-64.

PMID:
9085405
10.

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings.

Bradwejn J, Koszycki D, Shriqui C.

Arch Gen Psychiatry. 1991 Jul;48(7):603-10.

PMID:
2069490
11.

Increased left posterior parietal-temporal cortex activation after D-fenfluramine in women with panic disorder.

Meyer JH, Swinson R, Kennedy SH, Houle S, Brown GM.

Psychiatry Res. 2000 May 15;98(3):133-43.

PMID:
10821996
12.

Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings.

Wiedemann K, Jahn H, Yassouridis A, Kellner M.

Arch Gen Psychiatry. 2001 Apr;58(4):371-7.

PMID:
11296098
13.

Functional magnetic resonance imaging characterization of CCK-4-induced panic attack and subsequent anticipatory anxiety.

Schunck T, Erb G, Mathis A, Gilles C, Namer IJ, Hode Y, Demaziere A, Luthringer R, Macher JP.

Neuroimage. 2006 Jul 1;31(3):1197-208.

PMID:
16600640
14.

Effect of aging on cholecystokinin-induced panic.

Flint AJ, Koszycki D, Vaccarino FJ, Cadieux A, Boulenger JP, Bradwejn J.

Am J Psychiatry. 1998 Feb;155(2):283-5.

PMID:
9464213
15.

[The mechanism of controlling regional cerebral blood flow in patients with localization-related epilepsy].

Katayama S, Momose T, Sano I, Nakashima Y, Nakajima T, Niwa S, Matsushita M.

Seishin Shinkeigaku Zasshi. 1996;98(2):89-114. Japanese.

PMID:
8935829
16.

Impact of state and trait anxiety on the panic response to CCK-4.

Eser D, Wenninger S, Baghai T, Schüle C, Rupprecht R.

J Neural Transm (Vienna). 2008 Jun;115(6):917-20. doi: 10.1007/s00702-008-0047-2.

PMID:
18414777
17.

Neural mechanisms underlying melodic perception and memory for pitch.

Zatorre RJ, Evans AC, Meyer E.

J Neurosci. 1994 Apr;14(4):1908-19.

18.

One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI.

Schunck T, Mathis A, Erb G, Namer IJ, Hode Y, Demazières A, Luthringer R.

J Psychopharmacol. 2011 Jan;25(1):52-9. doi: 10.1177/0269881110367449.

PMID:
20498136
19.

Effects of the cholecystokinin agonist pentagastrin in patients with generalized anxiety disorder.

Brawman-Mintzer O, Lydiard RB, Bradwejn J, Villarreal G, Knapp R, Emmanuel N, Ware MR, He Q, Ballenger JC.

Am J Psychiatry. 1997 May;154(5):700-2.

PMID:
9137133
20.

Effects of cholecystokinin tetrapeptide on respiratory function in healthy volunteers.

Bradwejn J, LeGrand JM, Koszycki D, Bates JH, Bourin M.

Am J Psychiatry. 1998 Feb;155(2):280-2.

PMID:
9464212

Supplemental Content

Support Center